BENKOWITZ MICHAEL (PRESIDENT AND COO) sold 14.63K shares of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $6.80M. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−14.63K
Price / share
$117.76
Trade value
$1.72M
% of position
Common Stock
Shares
−116.00
Price / share
$456.87
Trade value
$53K
% of position
Common Stock
Shares
−692.00
Price / share
$457.92
Trade value
$316.88K
% of position
Common Stock
Shares
−700.00
Price / share
$458.74
Trade value
$321.12K
% of position
Common Stock
Shares
−498.00
Price / share
$459.87
Trade value
$229.01K
% of position
Common Stock
Shares
−503.00
Price / share
$461.12
Trade value
$231.94K
% of position
Common Stock
Shares
−2.46K
Price / share
$463.26
Trade value
$1.14M
% of position
Common Stock
Shares
−2.27K
Price / share
$464.06
Trade value
$1.06M
% of position
Common Stock
Shares
−1.79K
Price / share
$465.11
Trade value
$834.41K
% of position
Common Stock
Shares
−1.05K
Price / share
$466.06
Trade value
$491.70K
% of position
Common Stock
Shares
−596.00
Price / share
$467.09
Trade value
$278.39K
% of position
Common Stock
Shares
−2.92K
Price / share
$468.12
Trade value
$1.37M
% of position
Common Stock
Shares
−837.00
Price / share
$469.18
Trade value
$392.70K
% of position
Common Stock
Shares
−156.00
Price / share
$470.37
Trade value
$73.38K
% of position
Common Stock
Shares
−26.00
Price / share
$470.75
Trade value
$12.24K
% of position
Net shares
−29.25K
Net value
-$8.52M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/20/2026 | M · Option Exercise | −14.63K | $117.76 | $1.72M | 50.0% | 29.25K | 14.63K |
| Common Stock Indirect | 1/20/2026 | S · Sale | −116.00 | $456.87 | $53K | 0.8% | 14.63K | 14.51K |
| Common Stock Indirect | 1/20/2026 | S · Sale | −692.00 | $457.92 | $316.88K | 4.8% | 14.51K | 13.82K |
| Common Stock Indirect | 1/20/2026 | S · Sale | −700.00 | $458.74 | $321.12K | 5.1% | 13.82K | 13.12K |
| Common Stock Indirect | 1/20/2026 | S · Sale | −498.00 | $459.87 | $229.01K | 3.8% | 13.12K | 12.62K |
| Common Stock Indirect | 1/20/2026 | S · Sale | −503.00 | $461.12 | $231.94K | 4.0% | 12.62K | 12.12K |
| Common Stock Indirect | 1/20/2026 | S · Sale | −2.46K | $463.26 | $1.14M | 20.3% | 12.12K | 9.66K |
| Common Stock Indirect | 1/20/2026 | S · Sale | −2.27K | $464.06 | $1.06M | 23.5% | 9.66K | 7.39K |
| Common Stock Indirect | 1/20/2026 | S · Sale | −1.79K | $465.11 | $834.41K | 24.3% | 7.39K | 5.59K |
| Common Stock Indirect | 1/20/2026 | S · Sale | −1.05K | $466.06 | $491.70K | 18.9% | 5.59K | 4.54K |
| Common Stock Indirect | 1/20/2026 | S · Sale | −596.00 | $467.09 | $278.39K | 13.1% | 4.54K | 3.94K |
| Common Stock Indirect | 1/20/2026 | S · Sale | −2.92K | $468.12 | $1.37M | 74.1% | 3.94K | 1.02K |
| Common Stock Indirect | 1/20/2026 | S · Sale | −837.00 | $469.18 | $392.70K | 82.1% | 1.02K | 182.00 |
| Common Stock Indirect | 1/20/2026 | S · Sale | −156.00 | $470.37 | $73.38K | 85.7% | 182.00 | 26.00 |
| Common Stock Indirect | 1/20/2026 | S · Sale | −26.00 | $470.75 | $12.24K | New position | 26.00 | 0.00 |
| Total | −29.25K | -$8.52M | ||||||
Common Stock
Common Stock
14.63K shares
Shares
−14.63K
Strike price
146.03
Held after
67.88K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Stock Indirect | Common Stock14.63K shares | 1/20/2026 | M · Option Exercise | −14.63K | 146.03 | — | 67.88K |
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.65K | Direct |
| Total | 2.65K | 2.65K direct |